Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce D Wines

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Cell Reports. Medicine|May 17, 2021
Decay of Fc-dependent antibody functions after mild to moderate COVID-19Wen Shi Lee, Kevin John Selva, Samantha K Davis, et al.
Science Translational Medicine|August 11, 2017
Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infectionMatthew S Parsons, Sarah B Lloyd, Wen Shi Lee, et al.
Ebiomedicine|December 30, 2021
Adults with Plasmodium falciparum malaria have higher magnitude and quality of circulating T-follicular helper cells compared to childrenDamian A Oyong, Jessica R Loughland, Megan S F Soon, et al.
Journal of Virology|May 26, 2017
Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment InterruptionWen Shi Lee, Anne B Kristensen, Thomas A Rasmussen, et al.
Nature Communications|March 20, 2021
Mechanisms and targets of Fcγ-receptor mediated immunity to malaria sporozoitesGaoqian Feng, Bruce D Wines, Liriye Kurtovic, et al.
Frontiers in Immunology|September 5, 2018
The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1Jessica C Anania, Halina M Trist, Catherine S Palmer, et al.
Medical Microbiology and Immunology|July 21, 2023
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variantsEbene R Haycroft, Samantha K Davis, Pradhipa Ramanathan, et al.
JCI Insight|September 22, 2023
Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infectionsKevin J Selva, Pradhipa Ramanathan, Ebene R Haycroft, et al.
Vaccine|June 17, 2025
Genetic markers of enhanced functional antibody responses to COVID-19 vaccinationRuth A Purcell, L Carissa Aurelia, Lilith F Allen, et al.
Frontiers in Immunology|June 10, 2017
A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine RegimensSven Kratochvil, Paul F McKay, Jakub T Kopycinski, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Cell Reports. Medicine|May 17, 2021
Decay of Fc-dependent antibody functions after mild to moderate COVID-19Wen Shi Lee, Kevin John Selva, Samantha K Davis, et al.
Science Translational Medicine|August 11, 2017
Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infectionMatthew S Parsons, Sarah B Lloyd, Wen Shi Lee, et al.
Ebiomedicine|December 30, 2021
Adults with Plasmodium falciparum malaria have higher magnitude and quality of circulating T-follicular helper cells compared to childrenDamian A Oyong, Jessica R Loughland, Megan S F Soon, et al.
Journal of Virology|May 26, 2017
Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment InterruptionWen Shi Lee, Anne B Kristensen, Thomas A Rasmussen, et al.
Nature Communications|March 20, 2021
Mechanisms and targets of Fcγ-receptor mediated immunity to malaria sporozoitesGaoqian Feng, Bruce D Wines, Liriye Kurtovic, et al.
Frontiers in Immunology|September 5, 2018
The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1Jessica C Anania, Halina M Trist, Catherine S Palmer, et al.
Medical Microbiology and Immunology|July 21, 2023
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variantsEbene R Haycroft, Samantha K Davis, Pradhipa Ramanathan, et al.
JCI Insight|September 22, 2023
Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infectionsKevin J Selva, Pradhipa Ramanathan, Ebene R Haycroft, et al.
Vaccine|June 17, 2025
Genetic markers of enhanced functional antibody responses to COVID-19 vaccinationRuth A Purcell, L Carissa Aurelia, Lilith F Allen, et al.
Frontiers in Immunology|June 10, 2017
A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine RegimensSven Kratochvil, Paul F McKay, Jakub T Kopycinski, et al.
Pageof 9